119 related articles for article (PubMed ID: 38583573)
21. Molecular Mechanisms Driving the
Li X; Ke H; Wu W; Tu Y; Zhou H; Yu Y
mSphere; 2021 Dec; 6(6):e0085921. PubMed ID: 34935448
[TBL] [Abstract][Full Text] [Related]
22. Outbreak of NDM-5-producing
Zhu J; Wang G; Li M
mSystems; 2024 Apr; 9(4):e0136923. PubMed ID: 38506533
[TBL] [Abstract][Full Text] [Related]
23. Emergence and clonal expansion of Klebsiella pneumoniae ST307, simultaneously producing KPC-3 and NDM-1.
Cejas D; Magariños F; Elena A; Ferrara M; Ormazábal C; Yernazian MV; Gutkind G; Radice M
Rev Argent Microbiol; 2022; 54(4):288-292. PubMed ID: 35753832
[TBL] [Abstract][Full Text] [Related]
24. Ceftazidime-avibactam activity against a challenge set of carbapenem-resistant Enterobacterales: Ompk36 L3 alterations and β-lactamases with ceftazidime hydrolytic activity lead to elevated MIC values.
Castanheira M; Doyle TB; Hubler C; Sader HS; Mendes RE
Int J Antimicrob Agents; 2020 Jul; 56(1):106011. PubMed ID: 32417206
[TBL] [Abstract][Full Text] [Related]
25. Evolutionary Trajectories toward Ceftazidime-Avibactam Resistance in Klebsiella pneumoniae Clinical Isolates.
Carattoli A; Arcari G; Bibbolino G; Sacco F; Tomolillo D; Di Lella FM; Trancassini M; Faino L; Venditti M; Antonelli G; Raponi G
Antimicrob Agents Chemother; 2021 Sep; 65(10):e0057421. PubMed ID: 34339281
[TBL] [Abstract][Full Text] [Related]
26. The Potential Use of Ceftazidime-Avibactam Against Carbapenem Resistant
Nasomsong W; Nulsopapon P; Changpradub D; Pongchaidecha M; Pungcharoenkijkul S; Juntanawiwat P; Simsiriporn W; Santimaleeworagun W
Drug Des Devel Ther; 2021; 15():3095-3104. PubMed ID: 34295150
[TBL] [Abstract][Full Text] [Related]
27. Ceftazidime-Avibactam Resistance Associated with Increased
Coppi M; Di Pilato V; Monaco F; Giani T; Conaldi PG; Rossolini GM
Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31964792
[TBL] [Abstract][Full Text] [Related]
28. Loss and gain of ceftazidime-avibactam susceptibility in a non-carbapenemase-producing K1-ST23 hypervirulent
Zhao J; Pu D; Li Z; Zhang Y; Liu X; Zhuo X; Lu B; Cao B
Virulence; 2024 Dec; 15(1):2348251. PubMed ID: 38697754
[TBL] [Abstract][Full Text] [Related]
29. Outbreak of Klebsiella pneumoniae ST11 Resistant To Ceftazidime-Avibactam Producing KPC-31 and the Novel Variant KPC-115 during COVID-19 Pandemic in Argentina.
Nicola F; Cejas D; González-Espinosa F; Relloso S; Herrera F; Bonvehí P; Smayevsky J; Figueroa-Espinosa R; Gutkind G; Radice M
Microbiol Spectr; 2022 Dec; 10(6):e0373322. PubMed ID: 36445147
[TBL] [Abstract][Full Text] [Related]
30. Co-existence of virulence factors and antibiotic resistance in new Klebsiella pneumoniae clones emerging in south of Italy.
Fasciana T; Gentile B; Aquilina M; Ciammaruconi A; Mascarella C; Anselmo A; Fortunato A; Fillo S; Petralito G; Lista F; Giammanco A
BMC Infect Dis; 2019 Nov; 19(1):928. PubMed ID: 31684890
[TBL] [Abstract][Full Text] [Related]
31. Dynamic evolution of imipenem/relebactam resistance in a KPC-producing Klebsiella pneumoniae from a single patient during ceftazidime/avibactam-based treatments.
Gaibani P; Bovo F; Bussini L; Lazzarotto T; Amadesi S; Bartoletti M; Viale P; Ambretti S
J Antimicrob Chemother; 2022 May; 77(6):1570-1577. PubMed ID: 35373297
[TBL] [Abstract][Full Text] [Related]
32. Identification of Carbapenem-Resistant Klebsiella pneumoniae with Emphasis on New Delhi Metallo-Beta-Lactamase-1 (bla
Shoja S; Ansari M; Faridi F; Azad M; Davoodian P; Javadpour S; Farahani A; Mobarrez BD; Karmostaji A
Microb Drug Resist; 2018 May; 24(4):447-454. PubMed ID: 28972857
[TBL] [Abstract][Full Text] [Related]
33. Multidrug-resistant Klebsiella pneumoniae harboring extended spectrum β-lactamase encoding genes isolated from human septicemias.
Carvalho I; Chenouf NS; Carvalho JA; Castro AP; Silva V; Capita R; Alonso-Calleja C; Enes Dapkevicius MLN; Igrejas G; Torres C; Poeta P
PLoS One; 2021; 16(5):e0250525. PubMed ID: 33945553
[TBL] [Abstract][Full Text] [Related]
34. Effect of ceftazidime-avibactam combined with different antimicrobials against carbapenem-resistant
Wu Y; Yu W; Chu X; Zhang J; Jia P; Liu X; Zhu Y; Xu Y; Yang Q
Microbiol Spectr; 2024 Jun; 12(6):e0010724. PubMed ID: 38712934
[TBL] [Abstract][Full Text] [Related]
35. Omic insights into various ceftazidime-avibactam-resistant
Bongiorno D; Bivona DA; Cicino C; Trecarichi EM; Russo A; Marascio N; Mezzatesta ML; Musso N; Privitera GF; Quirino A; Scarlata GGM; Matera G; Torti C; Stefani S
Front Cell Infect Microbiol; 2022; 12():1010979. PubMed ID: 36683697
[TBL] [Abstract][Full Text] [Related]
36. Increased gene expression and copy number of mutated bla
Sun L; Li H; Wang Q; Liu Y; Cao B
BMC Microbiol; 2021 Aug; 21(1):230. PubMed ID: 34412588
[TBL] [Abstract][Full Text] [Related]
37. Multiplicity of
Arcari G; Polani R; Santilli S; Capitani V; Sacco F; Bruno F; Garcia-Fernandez A; Raponi G; Villa L; Gentile G; Carattoli A
Antimicrob Agents Chemother; 2023 Aug; 67(8):e0036823. PubMed ID: 37428086
[TBL] [Abstract][Full Text] [Related]
38.
Shields RK; Nguyen MH; Press EG; Chen L; Kreiswirth BN; Clancy CJ
Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28242667
[TBL] [Abstract][Full Text] [Related]
39. Klebsiella pneumoniae carbapenemase (KPC) producer resistant to ceftazidime-avibactam due to a deletion in the blaKPC3 gene.
Antinori E; Unali I; Bertoncelli A; Mazzariol A
Clin Microbiol Infect; 2020 Jul; 26(7):946.e1-946.e3. PubMed ID: 32061796
[TBL] [Abstract][Full Text] [Related]
40. Genomic analysis of a pan-resistant Klebsiella pneumoniae sequence type 11 identified in Japan in 2016.
Nishida S; Ono Y
Int J Antimicrob Agents; 2020 Apr; 55(4):105854. PubMed ID: 31770626
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
